Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting

2 years ago

Stella Diagnostics Designated as a Semi-Finalist for SAGES Shark Tank 2022Stella Diagnostics and Collaborators to Give a Clinical Science Data…

Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol

2 years ago

SOLANA BEACH, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating…

Cura Foundation and Sanford Health Win Two Awards in the Inaugural Anthem Awards

2 years ago

The Cura Foundation and Sanford Health are honored to be recognized as Silver Winners for Best Nonprofit Campaign and Best…

InnerScope Hearing Technologies (OTC: INND) Offers Hearing Products on Walmart Canada’s Flagship Online Store – Walmart.ca

2 years ago

InnerScope Offers its HearingAssist and iHear Branded Hearing Products and Related Supplies to more than 1.5 Million Customers that Visit…

Teknova to Report Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022

2 years ago

HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents…

Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism

2 years ago

– Notice of allowance received by Company’s licensor, The University of Sheffield (UK) bolsters intellectual property of AEZS-150 in development…

Codex DNA to Report Fourth Quarter 2021 Financial Results on Tuesday, March 22, 2022

2 years ago

SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology…

Catalyst Pharmaceuticals Further Strengthens FIRDAPSE® U.S. Patent Portfolio

2 years ago

Three New Patents Covering Additional Patient Amifampridine Metabolizer Types have been Allowed and will Issue in March 2022 Reinforces and…

F-star Therapeutics to Host Fourth Quarter and Full-Year 2021 Financial Results Conference Call on March 14, 2022

2 years ago

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company…

Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash

2 years ago

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March…